Novartis Investigative Site

Istanbul, Sultangazi 34295

0 studies enrolling now · 3 studies all time

What they study most

IgA Nephropathy, Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS — Running, not enrolling
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed